Showing results (51-60 of 211) with videos related to
Sort By:
Pageof 22
Developmental Medicine and Child Neurology|December 3, 2008
Sensory modulation disorder: a risk factor for participation in daily life activitiesTami Bar-Shalita, Jean-Jacques Vatine, Shula ParushResearch in Developmental Disabilities|February 4, 2025
Health-related quality of life and participation in adolescents: The role of ADHD, and co-occurrence of DCDShahar Zaguri-Vittenberg, Moriya Gellis, Hila Horovitz Hilman, et al.Reproductive Toxicology (Elmsford, N.Y.)|April 4, 2006
Herpes simplex virus and Epstein-Barr virus infections in pregnancy: consequences of neonatal or intrauterine infectionMeytal Avgil, Asher OrnoyReproductive Toxicology (Elmsford, N.Y.)|February 17, 2006
Pregnancy outcome following infections by coxsackie, echo, measles, mumps, hepatitis, polio and encephalitis virusesAsher Ornoy, Alexander TenenbaumBirth Defects Research|April 12, 2017
Parvovirus B19 infection during pregnancy and risks to the fetusAsher Ornoy, Zivanit ErgazPharmacogenomics|August 15, 2018
Clinical implications of selective serotonin reuptake inhibitors-selective serotonin norepinephrine reuptake inhibitors pharmacogenetics during pregnancy and lactationGideon Koren, Asher OrnoyExpert Review of Clinical Pharmacology|January 9, 2018
The role of the placenta in drug transport and fetal drug exposureGideon Koren, Asher OrnoyExpert Opinion on Drug Metabolism & Toxicology|January 19, 2018
Selective serotonin reuptake inhibitor use in pregnant women; pharmacogenetics, drug-drug interactions and adverse effectsAsher Ornoy, Gideon KorenHealth Economics Review|July 11, 2019
Cost effectiveness of optimal treatment of ADHD in Israel: a suggestion for national policyAsher Ornoy, Avia SpivakBirth Defects Research|July 18, 2017
Selective Serotonin Reuptake Inhibitors during Pregnancy: Do We Have Now More Definite Answers Related to Prenatal Exposure?Asher Ornoy, Gideon KorenPageof 22